In re Merck & Co., Inc. Securities Litigation Case Brief Summary | Law Case Explained скачать в хорошем качестве

In re Merck & Co., Inc. Securities Litigation Case Brief Summary | Law Case Explained

Get more case briefs explained with Quimbee. Quimbee has over 20,000 case briefs (and counting) keyed to over 223 casebooks ► https://www.quimbee.com/case-briefs-o... In re Merck & Co., Inc. Securities Litigation | 432 F.3d 261 (2005) Section Ten-B of the Securities Act of Nineteen Thirty-Four and Section Eleven of the Securities Act of Nineteen Thirty-Three are tools that investors use to rectify securities fraud. A plaintiff bringing a claim under either section must prove that the fraudulent statement or omission was material. In the case of In re Merck and Company Securities Litigation, the Third Circuit sought to define materiality. In January of two thousand two, Merck and Company, Incorporated announced a planned initial public offering, or I P O, of its subsidiary, Medco Health Solutions, Incorporated. Medco saved clients’ money by negotiating discounted rates with pharmacies. Customers paid their copayments directly to their pharmacies. However, Medco’s accounting policy was to recognize these copayments as revenue. Merck didn’t initially disclose this revenue on its securities form ten-K. On April seventeenth, two thousand two, Merck disclosed the revenue recognition, but not the total amount of copayments recognized. After this disclosure, Merck’s stock price rose three cents and continued to rise for the next five days. That June, The Wall Street Journal published an article reporting their estimate of the amount of copayments Medco recognized. After publication, Merck’s stock fell two dollars and twenty-two cents. In July, Merck finally disclosed the total amount of copayment revenue it recognized. Merck’s stock continued to fall, and Merck canceled the I P O. Union Investments Privatfonds G M B H brought suit on behalf of Merck stockholders. Union claimed that Merck withheld information and made misleading statements in violation of Sections Ten-B and Twenty-A of the nineteen thirty-four act and Section Eleven of the nineteen thirty-three act. Merck moved to dismiss. The district court granted dismissal. Union appealed to the Third Circuit. Want more details on this case? Get the rule of law, issues, holding and reasonings, and more case facts here: https://www.quimbee.com/cases/in-re-m... The Quimbee App features over 20,000 case briefs keyed to over 223 casebooks. Try it free for 7 days! ► https://www.quimbee.com/case-briefs-o... Have Questions about this Case? Submit your questions and get answers from a real attorney here:https://www.quimbee.com/cases/in-re-m... Did we just become best friends? Stay connected to Quimbee here: Subscribe to our YouTube Channel ► https://www.youtube.com/subscription_... Quimbee Case Brief App ► https://www.quimbee.com/case-briefs-o... Facebook ►   / quimbeedotcom   Twitter ►   / quimbeedotcom   #casebriefs #lawcases #casesummaries